🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2 open-label two cohort study of durvalumab plus monalizuma...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2025-02-24
Trial ID
NCT06503614
Treatments Being Tested
The study is intended to assess the safety and efficacy of perioperative tr...
Status
Recruiting
Location
Research Site
Start Date
2022-04-14
Trial ID
NCT05061550
This is a Phase III, randomised, double-blind, multicentre, international s...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-02-07
Trial ID
NCT05221840
Treatments Being Tested
Study D9108C00002 (NeoCOAST) is a platform study assessing the effectivenes...
Status
Completed
Location
Research Site
Start Date
2019-03-08
Trial ID
NCT03794544
Treatments Being Tested
This is a randomized trial evaluating the efficacy and safety of sequential...
Status
Not Yet Recruiting
Location
Montefiore Medical Center
Start Date
2026-09
Trial ID
NCT07146230
Treatments Being Tested
Research Hypothesis Lung cancer is the leading cause of cancer-related mort...
Status
Unknown
Location
Assistance Publique Hopitaux de Marseille
Start Date
2019-10-08
Trial ID
NCT03833440
Columbia 2 is a Phase 2 platform study to evaluate the safety and efficacy ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-10-01
Trial ID
NCT04145193
This phase I trial studies the safety of adding durvalumab to accelerated h...
Status
Completed
Location
Grady Health System
Start Date
2019-10-28
Trial ID
NCT03801902
The purpose of this study is to compare the clinical activity of durvalumab...
Status
Completed
Location
Research Site
Start Date
2018-12-19
Trial ID
NCT03822351
Treatments Being Tested
This is a multicenter, open-label, dose-escalation, dose-exploration and do...
Status
Active Not Recruiting
Location
Research Site
Start Date
2016-02-22
Trial ID
NCT02671435
Treatments Being Tested